TNXP Tonix Pharmaceuticals
- 0.1972
- +0.0156+8.59%
- 0.2000
- +0.0028+1.42%
Tonix Pharmaceuticals News
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase May 15, 2024 8:00am EDT Download as PDF CHATHAM, N.J., M
Tonix Pharmaceuticals | 10-Q: Quarterly report
Express News | Tonix Pharmaceuticals Q1 2024 GAAP EPS $(0.18) Beats $(0.39) Estimate, Sales $2.482M Miss $3.800M Estimate
Express News | Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
Express News | Tonix Pharmaceuticals Q1 Net Income USD -14.939 Million
Express News | Tonix Pharmaceuticals Q1 Operating Income USD -21.351 Million
Tonix Pharmaceuticals 1Q Loss/Shr 18c >TNXP
Tonix Pharmaceuticals 1Q Loss/Shr 18c >TNXP
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase April 24, 2024 8:00am EDT Download as PDF CHATHAM, N.J., April 24, 2024 (GLOBE NEW
Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
Express News | Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate
Tonix Pharmaceuticals 4Q Loss/Shr 86c >TNXP
Tonix Pharmaceuticals 4Q Loss/Shr 86c >TNXP
Press Release: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an overview of recent operational highlights.
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares traded lower by 7.2% to $0.17 Monday morning, hitting a new-all time low. The stock is trading lower on downward momentum after the company last
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. Nexalin Technology (NASD
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering.Toni
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday's regular session. The company's market cap stands at $17.6 million. Xilio Therapeutics (NASDAQ:XLO) stock rose 133.9
Express News | Tonix Pharmaceuticals Holding Shares Are Trading Lower After the Company Announced the Pricing of a $4.4 Million Registered Direct Offering
Express News | Tonix Pharmaceuticals Prices $4.4M Registered Direct Offering Of 14,666,666 Shares And Warrants At $0.30/Share; Warrants Have Exercise Price Of $0.33/Share
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering March 28, 2024 9:32am EDT Download as PDF CHATHAM, N.J., March 28, 2024
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation From The FDA For TNX-2900 For The Treatment Of Prader-Willi Syndrome
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating
Analysis
Price Target
No Data
